Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.55 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cystamine SCHEMBL1700588 | 1.00 | TSHR (0.55) | TSHRALDH1A1FGFR4THPOMAPT | |
| Cystamine SCHEMBL26133478 | 0.85 | TSHR (0.50) | TSHRALDH1A1FGFR4THPOMAPT | |
| Cystamine SCHEMBL31707345 | 0.85 | TSHR (0.50) | TSHRALDH1A1FGFR4THPOMAPT | |
| Cystamine SCHEMBL28091242 | 0.83 | MAPT (0.52) | TSHRALDH1A1FGFR4THPOMAPT | |
| Cystamine SCHEMBL28324594 | 0.83 | TSHR (0.48) | TSHRALDH1A1FGFR4THPOMAPT | |
| Acrylamide SCHEMBL514219 | 0.81 | ALDH1A1 (0.73) | TSHRALDH1A1FGFR4THPOTDP1 | |
| Acrylamide SCHEMBL6005592 | 0.81 | — | — | |
| Acrylamide SCHEMBL17685705 | 0.81 | ALDH1A1 (0.73) | TSHRALDH1A1FGFR4THPOTDP1 | |
| Cystamine SCHEMBL445194 | 0.78 | TSHR (0.62) | TSHRALDH1A1THPOMAPTTDP1 | |
| Cystamine SCHEMBL31646100 | 0.78 | TSHR (0.62) | TSHRALDH1A1THPOMAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112424242-B | Degradable microsphere and application thereof | 清华大学 | 2022-09-02 | — | — | CN | claimed |
| US-20210255074-A1 | Degradable Microsphere and Use Thereof | TSINGHUA UNIVERSITY (CN) | 2021-08-19 | — | — | US | claimed |
| EP-3808786-A1 | DEGRADABLE MICROSPHERE AND USE THEREOF | Tsinghua University (CN) | 2021-04-21 | — | — | EP | claimed |
| CN-112424242-A | Degradable microspheres and application thereof | 清华大学 | 2021-02-26 | — | — | CN | claimed |
| WO-2019237952-A1 | DEGRADABLE MICROSPHERE AND USE THEREOF | 清华大学 | 2019-12-19 | — | — | WO | claimed |
| CN-114891153-B | All-solid-state ion conductive elastomer and preparation method and application thereof | 中国科学院大学 | 2023-12-15 | — | — | CN | disclosed |
| CN-114644765-B | Composite ion hydrogel composition and preparation method and application thereof | 中国科学院上海硅酸盐研究所 | 2023-12-08 | — | — | CN | disclosed |
| CN-113082054-B | Stem cell transfected gene delivery vector and preparation method and application thereof | 中国药科大学 | 2023-09-26 | — | — | CN | disclosed |
| CN-116555392-A | Method for fixing sequencing microsphere on inner surface of gene sequencing chip | 赛纳生物科技(北京)有限公司 | 2023-08-08 | — | — | CN | disclosed |
| CN-116555408-A | Reusable sequencing method | 赛纳生物科技(北京)有限公司 | 2023-08-08 | — | — | CN | disclosed |
| CN-116531318-A | Preparation and application of pH/redox-responsive nanogel with chemotherapy/photothermal therapy/chemodynamic therapy | 首都医科大学 | 2023-08-04 | — | — | CN | disclosed |
| CN-113304700-B | Method for preparing magnetic polymer microsphere and application thereof | 上海科技大学 | 2023-06-02 | — | — | CN | disclosed |
| CN-116179668-A | Targeting reaction complexes and their use in targeted multiplex assays | 复旦大学 | 2023-05-30 | — | — | CN | disclosed |
| CN-112424242-B | Degradable microsphere and application thereof | 清华大学 | 2022-09-02 | — | — | CN | disclosed |
| US-20210255074-A1 | Degradable Microsphere and Use Thereof | TSINGHUA UNIVERSITY (CN) | 2021-08-19 | — | — | US | disclosed |
| EP-3808786-A1 | DEGRADABLE MICROSPHERE AND USE THEREOF | Tsinghua University (CN) | 2021-04-21 | — | — | EP | disclosed |
| CN-112424242-A | Degradable microspheres and application thereof | 清华大学 | 2021-02-26 | — | — | CN | disclosed |
| WO-2019237952-A1 | DEGRADABLE MICROSPHERE AND USE THEREOF | 清华大学 | 2019-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210255074-A1 | Degradable Microsphere and Use Thereof | STUB1, PSMD14, ACP1 | TSHR 3153/4885ALDH1A1 3389/4885FGFR4 1813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.